BOSTON SCIENTIFIC CORPORATION Remaining Share Repurchase Authorization
BOSTON SCIENTIFIC CORPORATION (BSX) had Remaining Share Repurchase Authorization of $3.00 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-08-03
- 2026-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.00B.
- 2019-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $535.00M.
- 2018-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $535.00M.
- 2017-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $535.00M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2026-06-30 | $3.00B 10-Q · filed 2026-08-03 |
| 2019-12-31 | $535.00M 10-K · filed 2020-02-25 |
| 2018-12-31 | $535.00M 10-K · filed 2019-02-19 |
| 2017-12-31 | $535.00M 10-K · filed 2018-02-20 |
| 2016-12-31 | $535.00M 10-K · filed 2017-02-23 |
| 2015-12-31 | $535.00M 10-K · filed 2016-02-24 |
| 2014-12-31 | $535.00M 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |